Monsenso’s digital companion solution accompanies new treatments, while complementing existing care pathways.
Our solution enables education about a new treatment, direct communication and data sharing to support the identification of treatment responders, high volume prescribers and outcomes to facilitate value-based agreements.
Our solution is a CE Class 1 medical device that captures ePRO, symptom and wearable device data to provide a holistic view of the patient journey.
Monsenso enables personalised support and patient data capture throughout the care journey.
Collects self-reported data and provides patients with tools to practice helpful skills in day-to-day life and promote medical adherence enabling them to better manage their condition between consultations.
Provide clinicians with insights into patients’ symptoms, adherence and outcomes to demonstrate the value of a treatment in a transparent way.
Demonstrate real-world value to regulators and payers to support coverage, differentiate from existing treatments,
value-based reimbursement and label expansion.
Monsenso’s digital companion solution complements existing therapies and care pathways by empowering patients to better understand and manage their mental health between clinical visits.
Monsenso enables direct communication and data sharing between all life sciences stakeholders, enabling a personalised medication and treatment approach and improving treatment adherence.
Our solution is highly scalable for global R&D projects. It can be used by small clinics, large hospitals and health systems in 10 languages. We can configure it to your specific requirements and deliver it as a white-label product.